Autoimmunity 2014
Home
Congress Information
Scientific Program
Registration
Accommodation
Family of Autoimmunity
SPONSORSHIP AND EXHIBITION
Useful Links
Bookmark and Share

Scheduled Industry Sponsored Symposia 

INDUSTRY SESSIONS NOT INCLUDED IN THE MAIN EVENT CME/CPD ACCREDITATION

BUILDING EFFECTIVE DIAGNOSTIC ALGORITHMS: FROM SELECTING METHODS TO EVALUATING ASSAY PERFORMANCE

Wednesday, March 26, 2014

16:00 - 17:30, Hall Athena

 

Chairperson

Steve Binder, Bio-Rad Laboratories, USA

 

16:00   ANA/ENA Detection and Measurement in SARDs: From Current Two-Step Strategy to the Future One-Step Approach

            Dr. Renato Tozzoli, M.D., Italy

16:20     Performance of Clinically Useful Phospholipid Antibody Assays

              Dr. Thomas Alexander, Ph.D., D(ABMLI), USA

16:40     Assessing Efficacy in ANCA Associated Vasculitis Testing

               Dr. Steve Holding, Ph.D., FRCPath, UK

17:00     Challenges and Opportunities for Celiac Disease Diagnosis

               Dr. Alessio Fasano, M.D., USA

17:20     Q&A

 


THE ROLE OF IL-6 IN RHEUMATOID ARTHRITIS: BASIC AND CLINICAL EVIDENCES OF TOCILIZUMAB TREATMENT

 

Thursday, March 27, 2014

12:30 - 14:00, Hall Athena



Chairpersons

Takao Koike, MD, PhD, NTT East Sapporo Hospital, Japan

Kazuhiko Yamamoto, MD, PhD, The University of Tokyo, Japan

 

12:30     IL-6 and Th17/T reg cell Imbalance in Rheumatoid Arthritis Patients

               Maxime Samson, MD, University of Burgundy, University Hospital of Dijon, France

13:00     The Significance of Inhibiting IL-6 in Rheumatoid Arthritis

               Tsutomu Takeuchi, MD, PhD, Keio University, School of Medicine, Japan

13:30     Accumulated Clinical Evidences of Tocilizumab

              Yoshiya Tanaka, MD, PhD, University of Occupational and Environmental Health, School of Medicine, Japan


THE CURRENT STATE AND ADVANCES IN AUTOIMMUNE DISEASE DIAGNOSIS

 


Friday March 28, 2014

12:30-14:00, Hall Athena

 

Chairpersons

Nicola Bizzaro, Italy

Nancy Agmon-Levin, Israel


12:30     Welcome and introduction

               Nicola Bizzaro, Nancy Agmon-Levin

12:35     International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear
              antibodies

              Nancy Agmon-Levin, Israel

12:50     From automated ANA on HEP2 screening, to multiplex and CLIA testing and the impact into the organization of the
              lab’s routine

              Xavier Bossuyt, Belgium

13:05     ANA screening and reflex testing: a model of workflow

              Elio Tonutti, Italy

13:10     New markers for the Sjögren’s syndrome

              Julian Ambrus Jr., USA

13:25     A new multidisciplinary approach on Autoimmunity testing through the new technologies

               Kishore Malyavantham, USA

13:40     Next scenarios on Autoimmunity: new tests, new technologies

               Nicola Bizzaro

13:50     Questions

 

 

THE ABC OF LUPUS: DISEASE ACTIVITY, B-CELLS & CLINICAL OUTCOMES

Saturday, March 29, 2014

12:30 - 14:00, Hall Athena

 

Chairperson

Eric Hachulla, France

 

12:30   Introduction
            
Eric Hachulla, France


12:40     How do B cells impact SLE pathology?

              Carlo Chizzolini, Switzerland

13:10     What is the role of biologics in the SLE treatment paradigm?

              Andrea Doria, Italy

13:40     What questions do you have?

               All

13:55     Conclusions

              Eric Hachulla, France